April Cashin-Garbutt

Natural Sciences

April graduated with a first-class honours degree in Natural Sciences from Pembroke College, University of Cambridge. During her time as Editor-in-Chief, News-Medical (2012-2017), she kickstarted the content production process and helped to grow the website readership to over 60 million visitors per year.

Through interviewing global thought leaders in medicine and life sciences, including Nobel laureates, April developed a passion for neuroscience and now works at the Sainsbury Wellcome Centre for Neural Circuits and Behaviour, located within UCL.

See less

Articles from April

Using whole genomes data to improve bowel cancer diagnosis: an interview with Professor Ian Tomlinson

The project aims to sequence the specified 100,000 genomes from two types of patients: first, those who may have rare inherited diseases caused by unknown or unidentified genes; and second, people with one of several types of cancer, including colorectal cancer.

9 Sep 2015

Why do we sleep? An interview with Professor Wisden

It is true that we still do not know why we need to sleep every night. Sleep is essential for health. We have to do it every day. But nobody yet knows why. This fact amazes me.

8 Sep 2015

Antibiotic resistance awareness: an interview with Professor Colin Garner

The threat of antibiotic resistance is very real. It is estimated that 700,000 people die each from resistant infections. In Europe the figure is 25,000 deaths and a similar number in the USA.

7 Sep 2015

Huntington’s disease prevention breakthrough? An interview with Professor Lesley Jones

Huntington’s disease is an inherited disease which, whilst quite rare, is one of the more common inherited neurodegenerative diseases. About 1 in 6,000 people in the UK are at risk and what’s horrible about this disease is that if one of your parents has it, then you have a fifty-fifty chance of inheriting it.

2 Sep 2015

Diagnosing traumatic brain injury through a blood test: an interview with Dr Korley

The severity of traumatic brain injury is currently crudely classified as mild, moderate or severe. However, often patients referred to as mild have debilitating symptoms that are not “mild”. Additionally, there are patients currently classified as moderate or severe who regain their pre-injury functional status whereas others don’t.

1 Sep 2015

Reducing hospital readmissions through Transitional Care: an interview with Rani Khetarpal

Services provided to a patient whose medical and/or psychosocial problems require moderate or high-complexity medical decision making during transitions in care from an inpatient setting, partial hospital, observation status in a hospital, or skilled nursing facility to the patient’s community setting.

27 Aug 2015

Understanding the causes of sudden death in epilepsy: an interview with Professor Sanjay Sisodiya

SUDEP is the sudden unexpected witnessed or unwitnessed, non-traumatic and non-drowning death in people with epilepsy, with or without evidence of a seizure. It doesn’t necessarily have to be in the known context of a seizure, excluding documented status epilepticus, where people have seizure after seizure.

24 Aug 2015

April Cashin-Garbutt

Articles from April

Using whole genomes data to improve bowel cancer diagnosis: an interview with Professor Ian Tomlinson

Why do we sleep? An interview with Professor Wisden

Antibiotic resistance awareness: an interview with Professor Colin Garner

Huntington’s disease prevention breakthrough? An interview with Professor Lesley Jones

Diagnosing traumatic brain injury through a blood test: an interview with Dr Korley

Reducing hospital readmissions through Transitional Care: an interview with Rani Khetarpal

Understanding the causes of sudden death in epilepsy: an interview with Professor Sanjay Sisodiya

Applying a top restaurant model to healthcare communications: an interview with Brandi Robinson, Sanofi

Determining the dynein-dynactin complex structure: an interview with Dr Gabriel C. Lander

DISC-1: schizophrenia's "Rosetta Stone" gene? An interview with Professor Kevin Fox

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News